Cargando…
USO1 expression is dysregulated in non-small cell lung cancer
BACKGROUND: USO1 vesicle transport factor (USO1) is a vesicular transport factor crucial for endoplasmic reticulum (ER) to Golgi transport and is required for transcytotic fusion and subsequent binding of the vesicles to the target membrane. USO1 has been studied in multiple cancers revealing high l...
Autores principales: | Keogh, Anna, Ryan, Lisa, Nur, Mutaz M., Baird, Anne-Marie, Nicholson, Siobhan, Cuffe, Sinéad, Fitzmaurice, Gerard J., Ryan, Ronan, Young, Vincent K., Finn, Stephen P., Gray, Steven G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554690/ https://www.ncbi.nlm.nih.gov/pubmed/36248341 http://dx.doi.org/10.21037/tlcr-22-230 |
Ejemplares similares
-
Altered expression of ACOX2 in non-small cell lung cancer
por: Sui, Jane S. Y., et al.
Publicado: (2022) -
An Analysis of JADE2 in Non-Small Cell Lung Cancer (NSCLC)
por: Murphy, Ciara, et al.
Publicado: (2023) -
MicroRNA expression profiling and biomarker validation in treatment-naïve and drug resistant non-small cell lung cancer
por: MacDonagh, Lauren, et al.
Publicado: (2021) -
In pursuit of synergy: An investigation of the PI3K/mTOR/MEK co-targeted inhibition strategy in NSCLC
por: Heavey, Susan, et al.
Publicado: (2016) -
Targeting the cancer stem cell marker, aldehyde dehydrogenase 1, to circumvent cisplatin resistance in NSCLC
por: MacDonagh, Lauren, et al.
Publicado: (2017)